ENDRA Life Sciences Files 8-K on Financials
Ticker: NDRA · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1681682
| Field | Detail |
|---|---|
| Company | Endra Life Sciences INC. (NDRA) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
ENDRA Life Sciences dropped an 8-K on July 9th detailing their financial situation. Check it out.
AI Summary
ENDRA Life Sciences Inc. filed an 8-K on July 9, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Ann Arbor, Michigan.
Why It Matters
This 8-K filing provides an update on ENDRA Life Sciences' financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any new material risks or events.
Key Players & Entities
- ENDRA Life Sciences Inc. (company) — Registrant
- July 9, 2025 (date) — Date of Report
- Ann Arbor, MI (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
FAQ
What specific financial information is being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on July 9, 2025.
Where are ENDRA Life Sciences Inc.'s principal executive offices located?
The principal executive offices are located at 3600 Green Court, Suite 350, Ann Arbor, MI 48105.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the SIC code for ENDRA Life Sciences Inc.?
The Standard Industrial Classification code is 3845, for ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding ENDRA Life Sciences Inc. (NDRA).